Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: A randomized, double-blind, placebo controlled trial

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 16, Issue 5, 2011, Pages

  López D'alessandro, Edgardo ^a   Escovich, Livia ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Alpha lipoic acid; Burning mouth syndrome; Gabapentin; Oral neuropathic pain; Pharmacological treatment ofburning mouth

Indexed keywords

CELLULOSE; GABAPENTIN; PLACEBO; THIOCTIC ACID;

ADULT; ARTICLE; BURNING MOUTH SYNDROME; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; NOCICEPTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE;

AMINES; BURNING MOUTH SYNDROME; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; THIOCTIC ACID;

EID: 80051772095     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.16942     Document Type: Article

References (20)

1. Palacios-Sánchez MF, Jordana-Comín X, García-Sívoli CE. Burning mouth syndrome: a retrospective study of 140 cases in a sample of Catalan population. Med Oral Patol Oral Cir Bucal. 2005;10:388-93.
2. Silvestre FJ, Serrano C. Burning mouth syndrome: concepts review and update. Med Oral. 1997;2:30-38.
3. Bergdahl J, Anneroth G. Burning mouth syndrome: literature review and model for research and management. J Oral Pathol Med. 1993;22:433-8.
4. Bogetto F, Maina G, Ferro G, Carbone M, Gandolfo S. Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med. 1998;60:378-85.
5. Basker RM, Main DM. The cause and management of burning mouth condition. Spec Care Dentist. 1991;11:89-96.
6. Chimenos-Kustner E, Marques-Soares MS. Burning mouth and saliva. Med Oral. 2002;7:244-53.
7. Bergdahl J. Psychologic aspects of patients with symptoms presumed to be caused by electricity or visual display units. Acta Odontol Scand. 1995;53:304-10.
8. Miyamoto SA, Ziccardi VB. Burning mouth syndrome. Mt Sinai J Med. 1998;65:343-7.
9. Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999;28:350-4.
10. Lauritano D, Spadari F, Formaglio F, Zambellini Artini M, Salvato A. Etiopathogenic, clinical-diagnostic and therapeutic aspects of the burning mouth syndrome. Research and treatment protocols in a patient group. Minerva Stomatol. 1998;47:239-51.
11. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis. 2000;6:274-7.
12. Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain. 2009;13:492-6.
13. Steele JC, Bruce AJ, Drage LA, Rogers RS 3rd. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth. Oral Dis. 2008;14:529-32.
14. Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial. J Oral Pathol Med. 2009;38:254-61.
15. White TL, Kent PF, Kurtz DB, Emko P. Effectiveness of gabapentin for treatment of burning mouth syndrome. Arch Otolaryngol Head Neck Surg. 2004;130:786-8.
16. Heckmann SM, Heckmann JG, Ungethüm A, Hujoel P, Hummel T. Gabapentin has little or no effect in the treatment of burning mouth syndrome - results of an open-label pilot study. Eur J Neurol. 2006;13:e6-7.
17. Femiano F, Gombos F, Scully C. Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral. 2004;9:8-13.
18. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry. 2002;63:38-43.
19. Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med. 2004;33:111-4.
20. López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil. 2009;36:52-7